期刊
JOURNAL OF BIOLOGICAL CHEMISTRY
卷 287, 期 13, 页码 9659-9671出版社
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M111.299537
关键词
-
资金
- Academy of Finland
- Finnish Cancer Organizations
- Foundation of the Finnish Cancer Institute
- Marie Curie Canceromics [MEXT-CT-2003-2728]
- Sigrid Juselius Foundation
- Turku University Foundation
- Turku University Central Hospital
The receptor-tyrosine kinase ErbB4 was identified as a direct regulator of hypoxia-inducible factor-1 alpha (HIF-1 alpha) signaling. Cleaved intracellular domain of ErbB4 directly interacted with HIF-1 alpha in the nucleus, and stabilized HIF-1 alpha protein in both normoxic and hypoxic conditions by blocking its proteasomal degradation. The mechanism of HIF stabilization was independent of VHL and proline hydroxylation but dependent on RACK1. ErbB4 activity was necessary for efficient HRE-driven promoter activity, transcription of known HIF-1 alpha target genes, and survival of mammary carcinoma cells in vitro. In addition, mammary epithelial specific targeting of Erbb4 in the mouse significantly reduced the amount of HIF-1 alpha protein in vivo. ERBB4 expression also correlated with the expression of HIF-regulated genes in a series of 4552 human normal and cancer tissue samples. These data demonstrate that soluble ErbB4 intracellular domain promotes HIF-1 alpha stability and signaling via a novel mechanism.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据